DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 156 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $564,000 | -84.6% | 16,600 | -83.4% | 0.14% | -85.9% |
| Q2 2021 | $3,661,000 | -18.4% | 100,000 | 0.0% | 0.97% | -18.5% |
| Q1 2021 | $4,484,000 | +57.2% | 100,000 | +100.0% | 1.19% | +52.2% |
| Q4 2020 | $2,853,000 | +227.2% | 50,000 | +194.1% | 0.78% | +176.2% |
| Q3 2020 | $872,000 | -12.3% | 17,000 | 0.0% | 0.28% | -14.5% |
| Q2 2020 | $994,000 | +42.6% | 17,000 | 0.0% | 0.33% | +3.8% |
| Q1 2020 | $697,000 | -34.1% | 17,000 | 0.0% | 0.32% | -16.5% |
| Q4 2019 | $1,057,000 | +83.2% | 17,000 | 0.0% | 0.38% | +42.7% |
| Q3 2019 | $577,000 | -74.8% | 17,000 | -77.9% | 0.27% | -75.4% |
| Q3 2018 | $2,286,000 | -24.5% | 77,000 | 0.0% | 1.09% | -6.6% |
| Q2 2018 | $3,028,000 | +96.4% | 77,000 | 0.0% | 1.16% | +93.2% |
| Q1 2018 | $1,542,000 | -11.7% | 77,000 | 0.0% | 0.60% | -2.3% |
| Q4 2017 | $1,746,000 | +265.3% | 77,000 | +208.0% | 0.62% | +231.2% |
| Q3 2017 | $478,000 | – | 25,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $72,236,000 | 20.73% |
| SV Health Investors, LLC | 449,951 | $26,871,000 | 18.64% |
| Redmile Group, LLC | 4,978,941 | $297,342,000 | 5.49% |
| Sunesis Advisors, LLC | 96,299 | $5,751,000 | 5.29% |
| Eversept Partners, LP | 418,652 | $25,001,897 | 3.43% |
| Opaleye Management Inc. | 222,000 | $13,081,000 | 2.64% |
| Avoro Capital Advisors LLC | 1,860,000 | $111,079,000 | 2.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 282,965 | $16,899,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 224,359 | $13,399,000 | 1.23% |
| Artal Group S.A. | 650,000 | $38,818,000 | 1.09% |